CMOs Bolster Formulation Capabilities with Hot Melt Extrusion

October 27, 2011
Bio/Pharmaceutical Outsources Report

Solubility enhancement is a recurring theme as bio/pharmaceutical companies push the bar to bring more novel technologies to market. One of the methods used to overcome the limitations of certain APIs is hot melt extrusion (HME), and several CMOs have bolstered their capabilities with addition of this technology.